Squamous Cell Carcinoma of tonsil, stained with p16 BOND Ready-to-Use Primary Antibody (6H12), PA0016

p16

p16
Antigen Background
p16 (INK4a) (Cyclin-dependent kinase inhibitor 2A (CDKN2A)) is a tumour suppressor protein associated with cell cycle progression, specifically in the regulation of transition from G1 phase of the cell cycle in to the S phase. Oncogenic mutations in the CDKN2A gene that encodes p16 (resulting in over or under expression of the protein) is associated with a wide range of cancers and cancer precursor lesions.
  • PA0016
    查看可用性
    7mL p16 (6H12) BOND RTU Primary
    6H12
    BOND RTU
    P (HIER)

产品规格

产品规格

PA0016
6H12
BOND RTU
P (HIER)
In Vitro Diagnostic Use
7ml

说明书

说明书

产品资料

产品资料

Antigen Background
p16 (INK4a) (Cyclin-dependent kinase inhibitor 2A (CDKN2A)) is a tumour suppressor protein associated with cell cycle progression, specifically in the regulation of transition from G1 phase of the cell cycle in to the S phase. Oncogenic mutations in the CDKN2A gene that encodes p16 (resulting in over or under expression of the protein) is associated with a wide range of cancers and cancer precursor lesions.

Recently Viewed

View All